Department of Clinical Pharmacy, Institute for Research and Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi Arabia.
College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi Arabia.
Bioorg Chem. 2020 May;98:103745. doi: 10.1016/j.bioorg.2020.103745. Epub 2020 Mar 12.
In this study, a series of indole based acetohydrazide derivatives (1-22) were synthesized and characterized by C NMR, H NMR and HREI-MS. The resulted derivatives were tested for thymidine phosphorylase inhibitory potential. These derivatives inhibited thymidine phosphorylase at different concentration ranging from 1.10 ± 0.10 to 41.10 ± 1.10 µM when compared with the standard 7-Deazaxanthine (IC value 38.68 ± 1.12 µM). The compound 8 having OH group at 2, 4 and 6 position was found the most potent among the series with IC 1.10 ± 0.10 µM. The structure activity relationships (SAR) has been established for all compounds keeping in the view the role of substitution and the effect of functional group which significantly affect thymidine phosphorylase activity. The nature of binding interactions of the most potent compounds and active sites of the enzymes was confirmed through molecular docking study.
在这项研究中,合成了一系列基于吲哚的乙酰肼衍生物(1-22),并通过 C NMR、H NMR 和 HREI-MS 进行了表征。所得衍生物被测试了胸苷磷酸化酶抑制潜力。与标准 7-脱氮黄嘌呤(IC 值 38.68 ± 1.12 μM)相比,这些衍生物在不同浓度下对胸苷磷酸化酶的抑制作用不同,范围为 1.10 ± 0.10 至 41.10 ± 1.10 μM。在系列化合物中,2、4 和 6 位具有 OH 基团的化合物 8 表现出最强的抑制活性,IC 50 为 1.10 ± 0.10 μM。考虑到取代基的作用和官能团的影响,建立了所有化合物的构效关系(SAR),这些因素对胸苷磷酸化酶活性有显著影响。通过分子对接研究证实了最有效化合物与酶活性部位的结合相互作用的性质。